[Congressional Record (Bound Edition), Volume 161 (2015), Part 8]
[House]
[Pages 11432-11435]
[From the U.S. Government Publishing Office, www.gpo.gov]




             BREAST CANCER AWARENESS COMMEMORATIVE COIN ACT

  Mr. LUETKEMEYER. Mr. Speaker, I move to suspend the rules and pass 
the bill (H.R. 2722) to require the Secretary of the Treasury to mint 
coins in recognition of the fight against breast cancer, as amended.
  The Clerk read the title of the bill.
  The text of the bill is as follows:

                               H.R. 2722

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``Breast Cancer Awareness 
     Commemorative Coin Act''.

     SEC. 2. FINDINGS.

       The Congress finds the following:
       (1) Breast cancer is the most common cancer among American 
     women, except for skin cancers. Today, about 1 in 8, or 12 
     percent of, women in the United States will develop invasive 
     breast cancer during their lifetime. This is an increase from 
     1 in 11, or 9 percent of, women in 1975.
       (2) Breast cancer is the second leading cause of cancer 
     death in women. The chance of dying from breast cancer is 
     about 1 in 36. Thanks to earlier detection, increased 
     awareness, and improved treatment, death rates from breast 
     cancer have decreased since about 1989.
       (3) There is a strong interest among the American public to 
     do more to tackle this disease. The National Cancer Institute 
     estimates $16.5 billion is spent in the United States each 
     year on breast cancer treatment. Assuming that incidence and 
     survival rates follow recent trends, it is estimated that 
     $17.2 billion will be spent on breast cancer care in the 
     United States in 2014.
       (4) Finding a cure for breast cancer is a goal of the 
     United States Government.
       (5) The National Institutes of Health dedicated an 
     estimated $674 million for breast cancer research in Fiscal 
     Year 2014. In Fiscal Year 2014, the Department of Defense's 
     Breast Cancer Research Program received $120 million.
       (6) While the National Institutes of Health and the 
     Department of Defense program on Breast Cancer research 
     remain the largest funders of breast cancer research in the 
     United States, in 2013, the National Cancer Institute funding 
     was reduced by nearly $66 million since 2011. The funding 
     level for the Department of Defense Breast Cancer Research 
     Program has remained consistent since 2012, however this 
     amount represents a 20-percent decrease from 2011 funding 
     levels.
       (7) Additional private sector support for breast cancer 
     research will help us find cures for breast cancer even 
     faster.
       (8) It is estimated that in the United States 231,840 women 
     will be diagnosed with and 40,290 women will die of cancer of 
     the breast in 2015. This means that every 13 minutes a woman 
     dies of breast cancer in the United States.
       (9) However, due to disease type and lack of adequate care, 
     African-American women have the highest death rates of all 
     racial and ethnic groups overall and are at least 44 percent 
     more likely to die of breast cancer as compared to other 
     racial and ethnic groups.
       (10) Breast cancer used to be considered a disease of aging 
     but recent trends show that more aggressive forms of the 
     disease have been increasingly diagnosed in younger women.
       (11) Breast cancer is the most frequently diagnosed cancer 
     among nearly every racial and ethnic group, including 
     African-American, American Indian/Alaska Native, Asian/
     Pacific Islander and Hispanic/Latina women.
       (12) Clinical advances, resulting from research, have led 
     to increased survival from breast cancer. Since 1990, death 
     rates from breast cancer have dropped over 34 percent.
       (13) Among men in the United States it is estimated that 
     there will be 2,350 new cases of invasive breast cancer and 
     440 breast cancer deaths in 2015.
       (14) At this time there are more than 3.1 million breast 
     cancer survivors in the United States.
       (15) It is estimated that breast cancer costs $12.5 billion 
     in lost productivity. Such productivity losses will increase 
     with projected growth rate and aging of the U.S. population 
     if cancer mortality rates stay constant in the future.
       (16) There is a better chance of survival and there are 
     more treatment options with early stage detection through 
     mammograms and clinical breast exams.
       (17) Breast cancer is the most common cancer in women 
     worldwide, with an estimated 1.7 million new cases of breast 
     cancer among women worldwide in 2012.
       (18) Breast Cancer Research Foundation (BCRF) is considered 
     one of the most efficient cancer research charities.
       (19) Of every dollar donated to BCRF, $0.91 goes to 
     research and awareness programs--88 cents towards research 
     and 3 cents towards awareness.
       (20) Founded in 1993, the BCRF has raised more than $500 
     million to fuel discoveries in tumor biology, genetics, 
     prevention, treatment, survivorship and metastasis, making 
     BCRF one of the largest private funders of breast cancer 
     research in the world. For 2014-2015, BCRF committed $58.6 
     million in research, including $11.6 million to the 
     international Evelyn H. Lauder Founder's Fund focused on 
     metastasis, to support the work of more than 220 researchers 
     at leading medical institutions across six continents (25 
     states and 14 countries).
       (21) Susan G. Komen (Komen) is the largest non-government 
     funder of breast cancer research, funding research that spans 
     the breast cancer continuum from basic biology to treatment 
     to survivorship.
       (22) Over the past 5 years, more than 80 cents of every 
     dollar spent by Komen has gone directly to its mission to 
     save lives and end breast cancer by empowering people, 
     ensuring quality care for all and energizing science to find 
     the cures.
       (23) Since its inception in 1982, Komen has invested more 
     than $2.6 billion towards its mission, including more than 
     $847 million in over 2400 research grants and 450 clinical 
     trials in 48 states and 21 different countries. Recent 
     funding has focused on research to stem metastatic and 
     aggressive disease, find scientifically sound preventive 
     strategies, and investigate environmental links to breast 
     cancer development.
       (24) Today, BCRF and Susan G. Komen continue their work to 
     advance research and support programs for patients and their 
     families.

     SEC. 3. COIN SPECIFICATIONS.

       (a) Denominations.--The Secretary of the Treasury 
     (hereafter in this Act referred to as the ``Secretary'') 
     shall mint and issue the following coins:
       (1) $5 gold coins.--Not more than 50,000 $5 gold coins, 
     which shall--
       (A) have a diameter of 0.850 inches; and
       (B) be made of ``pink gold'' which contains not less than 
     75 percent gold.
       (2) $1 silver coins.--Not more than 400,000 $1 coins, which 
     shall--
       (A) weigh 26.73 grams;
       (B) have a diameter of 1.500 inches; and
       (C) contain not less than 90 percent silver.
       (3) Half-dollar clad coins.--Not more than 750,000 half-
     dollar coins which shall--
       (A) weigh 11.34 grams;
       (B) have a diameter of 1.205 inches; and
       (C) be minted to the specifications for half-dollar coins 
     contained in section 5112(b) of title 31, United States Code.
       (b) Legal Tender.--The coins minted under this Act shall be 
     legal tender, as provided in section 5103 of title 31, United 
     States Code.
       (c) Numismatic Items.--For purposes of sections 5134 and 
     5136 of title 31, United States Code, all coins minted under 
     this Act shall be considered to be numismatic items.

     SEC. 4. DESIGN OF COINS.

       (a) Design Requirements.--
       (1) In general.--The design of the coins minted under this 
     Act shall be emblematic of the fight against breast cancer.
       (2) Designation and inscriptions.--On each coin minted 
     under this Act there shall be--
       (A) a designation of the face value of the coin;
       (B) an inscription of the year ``2018''; and

[[Page 11433]]

       (C) inscriptions of the words ``Liberty'', ``In God We 
     Trust'', ``United States of America'', and ``E Pluribus 
     Unum''.
       (b) Selection.--The design for the coins minted under this 
     Act shall be selected by the Secretary based on the winning 
     design from a juried, compensated design competition 
     described under subsection (c).
       (c) Design Competition.--
       (1) In general.--The Secretary shall hold a competition and 
     provide compensation for its winner to design the obverse and 
     reverse of the coins minted under this Act. The competition 
     shall be judged by an expert jury chaired by the Secretary 
     and consisting of 3 members from the Citizens Coinage 
     Advisory Committee who shall be elected by such Committee and 
     3 members from the Commission of Fine Arts who shall be 
     elected by such Commission.
       (2) Proposals.--As part of the competition described in 
     this subsection, the Secretary may accept proposals from 
     artists, engravers of the United States Mint, and members of 
     the general public, and any designs submitted for the design 
     review process described herein shall be anonymized until a 
     final selection is made.
       (3) Accompanying designs; preference for physical 
     designs.--The Secretary shall encourage 3-dimensional designs 
     to be submitted as part of the proposals, and the jury shall 
     give a preference for proposals that are accompanied by a 3-
     dimensional physical design instead of, or in addition to, an 
     electronic design.
       (4) Compensation.--The Secretary shall determine 
     compensation for the winning design under this subsection, 
     which shall be not less than $5,000. The Secretary shall take 
     into account this compensation amount when determining the 
     sale price described in section 6(a).

     SEC. 5. ISSUANCE OF COINS.

       (a) Quality of Coins.--Coins minted under this Act shall be 
     issued in uncirculated and proof qualities.
       (b) Period for Issuance.--The Secretary may issue coins 
     minted under this Act only during the 1-year period beginning 
     on January 1, 2018.

     SEC. 6. SALE OF COINS.

       (a) Sale Price.--The coins issued under this Act shall be 
     sold by the Secretary at a price equal to the sum of--
       (1) the face value of the coins;
       (2) the surcharge provided in section 7(a) with respect to 
     the coins; and
       (3) the cost of designing and issuing the coins (including 
     labor, materials, dies, use of machinery, overhead expenses, 
     marketing, and shipping).
       (b) Bulk Sales.--The Secretary shall make bulk sales of the 
     coins issued under this Act at a reasonable discount.
       (c) Prepaid Orders.--
       (1) In general.--The Secretary shall accept prepaid orders 
     for the coins minted under this Act before the issuance of 
     such coins.
       (2) Discount.--Sale prices with respect to prepaid orders 
     under paragraph (1) shall be at a reasonable discount.

     SEC. 7. SURCHARGES.

       (a) In General.--All sales of coins issued under this Act 
     shall include a surcharge of--
       (1) $35 per coin for the $5 coin;
       (2) $10 per coin for the $1 coin; and
       (3) $5 per coin for the half-dollar coin.
       (b) Distribution.--Subject to section 5134(f) of title 31, 
     United States Code, all surcharges which are received by the 
     Secretary from the sale of coins issued under this Act shall 
     be promptly paid by the Secretary as follows:
       (1) \1/2\ to the Susan G. Komen for the Cure, Dallas, 
     Texas, for the purpose of furthering research funded by the 
     organization.
       (2) \1/2\ to the Breast Cancer Research Foundation, New 
     York, New York, for the purpose of furthering research funded 
     by the Foundation.
       (c) Audits.--The surcharge recipients under subsection (b) 
     shall be subject to the audit requirements of section 
     5134(f)(2) of title 31, United States Code, with regard to 
     the amounts received under that subsection.
       (d) Limitations.--Notwithstanding subsection (a), no 
     surcharge may be included with respect to the issuance under 
     this Act of any coin during a calendar year if, as of the 
     time of such issuance, the issuance of such coin would result 
     in the number of commemorative coin programs issued during 
     such year to exceed the annual 2 commemorative coin program 
     issuance limitation under section 5112(m)(1) of title 31, 
     United States Code (as in effect on the date of the enactment 
     of this Act). The Secretary of the Treasury may issue 
     guidance to carry out this subsection.

  The SPEAKER pro tempore. Pursuant to the rule, the gentleman from 
Missouri (Mr. Luetkemeyer) and the gentlewoman from California (Ms. 
Maxine Waters) each will control 20 minutes.
  The Chair recognizes the gentleman from Missouri.


                             General Leave

  Mr. LUETKEMEYER. Mr. Speaker, I ask unanimous consent that all 
Members may have 5 legislative days in which to revise and extend their 
remarks and include extraneous material on the bill.
  The SPEAKER pro tempore. Is there objection to the request of the 
gentleman from Missouri?
  There was no objection.
  Mr. LUETKEMEYER. Mr. Speaker, I yield such time as he may consume to 
the gentleman from Texas (Mr. Sessions), the distinguished chairman of 
the Rules Committee.
  Mr. SESSIONS. Mr. Speaker, I appreciate the gentleman, my dear friend 
from Missouri, for this opportunity to allow me to speak today.
  Mr. Speaker, I rise today with my friends and colleagues, including 
the gentlewoman from New York, Congresswoman Carolyn B. Maloney, in 
support of H.R. 2722, the Breast Cancer Awareness Commemorative Coin 
Act.
  This bipartisan legislation supports research only and awareness with 
a new $1 gold minted coin, proceeds of which will benefit breast cancer 
research.
  Mr. Speaker, breast cancer research is one of the most important 
pieces of research that the Federal Government and other organizations 
perform on behalf of the American people and people all around the 
world. This is going to allow, for the first time ever, for these 
congressionally approved coins to be minted in pink gold in honor of 
the fight against breast cancer.
  Mr. Speaker, today, I wear this pin of the breast cancer fight. I 
applaud organizations all across the country that are not only trying 
to make progress in this issue, but are making sure that awareness 
about breast cancer and actual research to eliminate this deadly 
disease, that progress is being made. That is what the funds would do 
from private contributions of individuals all around the United States.
  There will be approximately 231,840 cases--new cases--of breast 
cancer among women and 2,350 new cases of breast cancer in men this 
year alone. That means that every 13 minutes, a woman will die of 
breast cancer in the United States, making breast cancer the second 
leading cause of death in women in the United States.
  I think it is important that we understand what we are trying to 
accomplish with this coin and this act today. The bottom line is that 
the United States Congress allows several organizations each year to be 
able to mint coins on behalf of highlighting the services that they 
offer to the American people.
  It comes at no cost to the taxpayers of this country. As a matter of 
fact, the Treasury makes a small amount of money as a result of their 
doing the work.
  Mr. Speaker, what will happen is that through this legislation 
today--that is very intricate and well understood--no money outside of 
any money that is brought to bear would be for anything other than 
breast cancer research. I am aware of the sensitivity of taxpayer money 
and how that might be used, but no taxpayer money would be used for 
this effort today.
  I want to recognize not only the people in breast cancer research, 
but also many of the survivors all across this country who are 
recognizing that the awareness and highlighting this project and the 
money that would be brought to bear of how important that is.
  I would say to my colleagues today that breast cancer research cannot 
be done entirely through taxpayer money. We are counting on outside 
money. This is allowing the American people to buy coins, just as we 
did when I handled the Boy Scout coin with the 100th anniversary of the 
Boy Scouts several years ago. People who were part of the Boy Scouts of 
America paid money in, and it helped us to sell the coin and to 
celebrate the 100th anniversary of the Boy Scouts.
  That is exactly what this coin would do also. It would be money from 
citizens all across this country that would highlight breast cancer 
awareness and the research dollars that would come as a result of that. 
That is why we are here today, the incredible medical research that is 
improving the lives of those who are diagnosed and undergoing treatment 
for breast cancer.
  Mr. Speaker, I believe this is the right thing to do for breast 
cancer research, and I want to thank my colleague, Carolyn B. Maloney, 
who has

[[Page 11434]]

been doing this bill, not only for the hard work necessary to get 290 
Members of Congress to say we want to vote on this bill, but also the 
awareness that, if we will join ranks with millions of people who are 
back home in our congressional districts who want to see breast cancer 
be solved in our lifetime, that it means that it would be all of us 
across this country.
  I want to thank the gentleman who is handling this on behalf of the 
Financial Services Committee, the gentleman from Missouri, for his 
great work. I think that this is an overwhelmingly bipartisan bill 
where the money will go 100 percent for research, not a dime of 
taxpayer dollars, and it is a well-understood process that is in the 
best interests of cancer research for our country.
  Mr. Speaker, I want to thank the gentleman.
  Mr. LUETKEMEYER. Mr. Speaker, I reserve the balance of my time.
  Ms. MAXINE WATERS of California. Mr. Speaker, I yield myself such 
time as I may consume.
  Mr. Speaker, I rise today to speak in favor of H.R. 2722, introduced 
by my distinguished colleague on the Financial Services Committee, 
Representative Carolyn B. Maloney, the ranking member of the Financial 
Services Subcommittee on Capital Markets and Government Sponsored 
Enterprises.
  I commend the gentlewoman for introducing the bill before us today, 
the Breast Cancer Awareness Commemorative Coin Act, which provides a 
chance for all of us to come together to raise awareness about this 
critical health issue that impacts the lives of so many women and 
families.
  Mr. Speaker, the statistics are startling. Approximately one in eight 
women in the United States will develop invasive breast cancer during 
her lifetime; and many of these women, approximately 1 in 36, will lose 
their lives from this horrible disease.
  This means that every 13 minutes, a woman in this country will die 
from breast cancer. That is 40,290 women in the United States are 
expected to die from breast cancer in 2015 alone.

                              {time}  1245

  While this disease affects women in every community across this 
country for a variety of reasons, such as the lack of adequate care, 
the likelihood of dying from the disease is particularly high for 
African American women. In fact, African American women had a 44 
percent higher rate of breast cancer mortality than White women. That 
is why the conversation we are having here today is so important.
  With increased awareness, early detection, new research, and better 
medicine, we can save lives, thousands of them each year. If 
consideration of the bill before us today causes at least one woman to 
get screened for breast cancer, we will be better off for it.
  I urge my colleagues to support the bill before us today, which will 
help raise awareness and modest sums for the fight against breast 
cancer.
  Again, I urge adoption of the bill, and I reserve the balance of my 
time.
  Mr. LUETKEMEYER. Mr. Speaker, I reserve the balance of my time.
  Ms. MAXINE WATERS of California. Mr. Speaker, I yield such time as 
she may consume to the gentlewoman from New York (Mrs. Carolyn B. 
Maloney), the author of this legislation.
  Mrs. CAROLYN B. MALONEY of New York. Mr. Speaker, I thank my good 
friend and colleague from the great State of California for yielding me 
the time and for her leadership in so many important areas before this 
body.
  Mr. Speaker, I am very, very proud to rise today to urge the passage 
of H.R. 2722, the Breast Cancer Awareness Commemorative Coin Act, a 
bill that I authored with my good friend and colleague, Congressman 
Pete Sessions from Texas. I also want to add my thanks to Chairman 
Hensarling, Ranking Member Maxine Waters of the Financial Services 
Committee, and the House leadership for bringing this bill so quickly 
to the floor.
  And a very special thank-you to my partner in this effort, 
Congressman Sessions, who has worked with great commitment and, I would 
say, creativity in bringing this bill forward and has selflessly worked 
to have it passed in this body. With his leadership, we were able to 
secure over 307 cosponsors supporting the passage of this bill in 
writing.
  What we are doing together with this bill is we are going to save 
American lives. I am absolutely delighted that Senator Heidi Heitkamp 
from North Dakota, who is, herself, a breast cancer survivor, has 
pledged to put 100 percent of her effort to making sure that the 
passage of this bill happens in the United States Senate.
  In the United States, over 200,000 new cases of breast cancer will be 
diagnosed this year, and more than 40,000 women will die. Breast cancer 
is the second leading cause of cancer death in women, and over 2,000 
men will be diagnosed. Many people think that it is a woman's disease, 
but there will be, on average, over 400 men a year who will die from 
breast cancer. There is only one thing, and one thing only, that can 
possibly save these lives, and that is research.
  The Breast Cancer Commemorative Coin Act will create the opportunity 
to raise millions of dollars for badly needed breast cancer research 
without spending one taxpayer dime. Money buys research, and research 
saves lives. Make no mistake, there have been significant advances in 
medical research and better detection efforts over the years. But 
40,000 women are still dying every year, and so much more needs to be 
done.
  I suspect that absolutely everyone in this body and everyone who is 
listening who hears my voice today knows someone that they love, some 
woman they admire, some family member that they care for who has been 
touched by the shadow of breast cancer. Through this bill, we offer 
them hope.
  Our bill directs the U.S. Mint to create up to 50,000 $5 gold coins, 
400,000 silver dollars, and 750,000 clad commemorative coins and make 
them available for purchase by the public throughout 2018 so that the 
American public can be involved with their dollars themselves making a 
decision to support breast cancer research.
  These coins will feature designs submitted and judged through a 
national art competition that will symbolize the fight against this 
terrible disease. The gold coin will be unique, made out of the 
beautiful, highly-prized pink gold to reflect the pink ribbon, an 
international symbol of breast cancer awareness. Like the ribbon, we 
hope that Americans across this Nation will be wearing the pink gold 
coin.
  Actually, Mr. Speaker, there has never been a pink gold commemorative 
coin made like this in U.S. history. This will be another congressional 
first.
  This bill is a creative way to raise awareness about breast cancer 
entirely from private funds for critically needed research that is 
necessary to find a cure. The proceeds will be split between two 
outstanding organizations: the Breast Cancer Research Foundation and 
Susan G. Komen. Over the years, the Breast Cancer Research Foundation 
and Komen each have raised hundreds of millions of dollars for breast 
cancer research across this Nation.
  I am privileged to represent the Breast Cancer Research Foundation 
and appreciate the constant support and effort from its founder, Evelyn 
Lauder, who has passed but created this wonderful organization, and 
Myra Biblowit, president of the Breast Cancer Research Foundation. The 
Research Foundation has been responsible for many of the cures that 
have come forward and breakthroughs.
  There are 3.1 million Americans alive today because of cures that 
have been financed by the Breast Cancer Research Foundation and Komen. 
Both organizations have low administrative cost rates so that the 
majority of every dollar received goes directly to research. For 
instance, for every dollar donated to the Breast Cancer Research 
Foundation, 91 cents goes directly to research, and that is incredibly 
important.
  The bill requires that every dollar generated through the coin 
program must also be matched by private fundraising dollars that are 
raised by these two organizations. The coin program has the potential 
to raise millions of

[[Page 11435]]

dollars to save lives--and at absolutely no cost to the American 
taxpayer. It can raise as much as $8 million. The money will buy 
research, and the research will save lives. When so many lives are on 
the line, every dollar counts, every dollar matters.
  I thank my colleagues, particularly my partner in this effort, 
Congressman Sessions, for their support, and I urge their continued 
bipartisan support in passing the Breast Cancer Commemorative Coin Act.
  Mr. LUETKEMEYER. Mr. Speaker, I reserve the balance of my time.
  Ms. MAXINE WATERS of California. Mr. Speaker, I have no additional 
speakers, and I yield back the balance of my time.
  Mr. LUETKEMEYER. Mr. Speaker, I yield myself such time as I may 
consume.
  Just to reiterate, the gentleman from Texas and the fine ladies from 
New York and California have really done a good job of explaining this 
bill. The importance of this, the fact that we are going to try and go 
after one of the Nation's leading killers, a disease that has claimed 
many lives, I think it is important to show that the bipartisan support 
here and the well wishes and good intentions of the group are something 
where it is nice to see something like this happen in Congress.
  I urge support of the bill, and I yield back the balance of my time.
  Mr. GRAVES of Louisiana. Mr. Speaker, breast cancer is the most 
common cancer among American women, except for skin cancers. In fact, 
current statistics show that about 1 in 8 women in the United States 
will develop invasive breast cancer during their lifetime. It is 
estimated that in the United States 231,840 women will be diagnosed 
with and 40,290 women will die of cancer of the breast in 2015. This 
means that every 13 minutes a woman dies of breast cancer in the United 
States.
  Due to early detection, increased awareness and improved approaches 
to treatment, death rates from breast cancer have decreased since 1989, 
but it is still the second leading cause of death in women. It is the 
most frequently diagnosed cancer among nearly every racial and ethnic 
group, including African American, American Indian, Alaska native, 
Asian/Pacific Islander and Hispanic/Latina women. African-American 
women have the highest death rates of all racial and ethnic groups 
overall and are at least 44 percent more likely to die of breast cancer 
as compared to other racial and ethnic groups. This is largely due to 
disease type and lack of adequate care.
  Approximately $16.5 billion is spent on breast cancer treatment in 
the United States according to the National Cancer Institute (NCI). The 
NCI also estimates that the cost of breast cancer treatment will 
continue to rise if current trends hold steady. Finding a cure for 
breast cancer is in the best interest of the American public and is a 
goal of the United States government.
  While combined funding for breast cancer research through the 
National Institutes of Health, the Department of Defense's Breast 
Cancer Research Program and the National Cancer Institute approaches 
one billion dollars, additional private sector support for breast 
cancer research will help us find a cure even faster.
  H.R. 2722, the Breast Cancer Awareness Commemorative Coin Act is 
designed to generate additional funding for breast cancer research at 
no cost to taxpayers. The bill compels the U.S. Treasury to raise money 
for breast cancer research through the sale of $5 pink gold coins, and 
$1 silver commemorative coins in 2018. The additional funding for 
breast cancer research will aid the efforts currently underway to find 
a cure for this deadly cancer.
  This week, it was brought to the attention of this body that the 
largest non-government funder of breast cancer research and initially 
selected as one of the recipients of breast cancer research funding 
pursuant to H.R. 2722, issues grants to Planned Parenthood. This 
development gave me pause and conflicted with my well-established pro-
life convictions. While I commend work on breast cancer research, I am 
against any direct or indirect federal funding for abortion.
  I was pleased that we were able to resolve the issue by amending the 
recipient of funds generated pursuant to the Breast Cancer Awareness 
Commemorative Coin Act, H.R. 2722 and designating 100% of the funds to 
the Breast Cancer Research Foundation. I supported the amended version 
of H.R. 2722 and was proud to see this legislation pass through the 
House. I encourage my colleagues in the Senate take up this bill so 
that we can move forward with the good and necessary work of pursuing a 
cure for the most common cancer in women worldwide.
  The SPEAKER pro tempore. The question is on the motion offered by the 
gentleman from Missouri (Mr. Luetkemeyer) that the House suspend the 
rules and pass the bill, H.R. 2722, as amended.
  The question was taken.
  The SPEAKER pro tempore. In the opinion of the Chair, two-thirds 
being in the affirmative, the ayes have it.
  Mr. AMASH. Mr. Speaker, on that I demand the yeas and nays.
  The yeas and nays were ordered.
  The SPEAKER pro tempore. Pursuant to clause 8 of rule XX, further 
proceedings on this motion will be postponed.

                          ____________________